Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)

Amylyx Pharmaceuticals has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.0 in Q3 2025.

• On a quarterly basis, Asset Utilization Ratio fell 100.34% year-over-year to 0.0 in Q3 2025; TTM through Sep 2025 was 0.0, a 100.34% decrease from a year earlier, with the FY2024 full-year figure at 0.25, down 70.66% from the prior year.
• Asset Utilization Ratio was 0.0 for Q3 2025 at Amylyx Pharmaceuticals, down from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.85 in Q1 2024, with the low at 0.0 in Q3 2025.
• Average Asset Utilization Ratio over 4 years is 0.41, with a median of 0.42 recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 884.63% in 2023, then tumbled 100.34% in 2025.
• Over 4 years, Asset Utilization Ratio stood at 0.08 in 2022, then soared by 884.63% to 0.77 in 2023, then sank by 47.98% to 0.4 in 2024, then slumped by 100.57% to 0.0 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025), per Business Quant data.